Literature DB >> 23575756

Can lungs be taken for transplantation from donors with a significant smoking history?

Saina Attaran1, Andrew Chukwuemeka, Jon R Anderson.   

Abstract

A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was 'Can lungs be taken for transplantation from donors with a significant smoking history?’. Five papers were found using the reported search that represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. These studies compared the outcome and survival between patients who receive lungs from smokers with those receiving non-smoker lungs. None of these studies were randomized controlled trials. They retrospectively analysed a cohort of patients undergoing lung transplantation for the past 10 years. These studies showed worse outcomes in the early postoperative period, such as longer intensive care unit stay, longer ventilation time and higher early postoperative mortality, with lungs harvested from smokers. Two studies also demonstrated a worse long-term outcome in recipients of lungs from smokers, whereas the other two showed worse results during the early postoperative period only. These latter two studies reported similar survival rates after 3 months and up to 3 years in recipients receiving smoker vs non-smoker lungs. One study, however, showed a better 5-year survival with smoker lungs compared with non-smokers, although in this study, lungs from heavy smokers showed the worse outcome. Despite the difference in long-term results and outcome reported by these authors, all of these studies unanimously indicate that lungs from smokers should not be rejected, as survival in these patients receiving smoker lungs is still significantly higher in 3 and 5 years compared with that in those who remain on the transplant waiting list. In conclusion, the current evidence in the literature suggests that lungs from smokers can be used for transplantation. Patients should, however, be fully informed of the risks involved with these lungs and the worse outcome compared with those receiving non-smoker lungs.

Entities:  

Mesh:

Year:  2013        PMID: 23575756      PMCID: PMC3686399          DOI: 10.1093/icvts/ivt141

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  10 in total

1.  Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry.

Authors:  Robert S Bonser; Rhiannon Taylor; David Collett; Helen L Thomas; John H Dark; James Neuberger
Journal:  Lancet       Date:  2012-05-29       Impact factor: 79.321

2.  Towards evidence-based medicine in cardiothoracic surgery: best BETS.

Authors:  Joel Dunning; Brian Prendergast; Kevin Mackway-Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

3.  Comparison of outcomes from smoking and nonsmoking donors: thirteen-year experience.

Authors:  Marius Berman; Kim Goldsmith; David Jenkins; Catherine Sudarshan; Pedro Catarino; Nair Sukumaran; John Dunning; Linda D Sharples; Steven Tsui; Jasvir Parmar
Journal:  Ann Thorac Surg       Date:  2010-12       Impact factor: 4.330

4.  The number of lung transplants can be safely doubled using extended criteria donors; a single-center review.

Authors:  Caroline Meers; Dirk Van Raemdonck; Geert M Verleden; Willy Coosemans; Herbert Decaluwe; Paul De Leyn; Philippe Nafteux; Toni Lerut
Journal:  Transpl Int       Date:  2010-01-05       Impact factor: 3.782

5.  Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects.

Authors:  M Ferson; A Edwards; A Lind; G W Milton; P Hersey
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

6.  Donor-acquired small cell lung cancer following pulmonary transplantation.

Authors:  A G De Soyza; J H Dark; D V Parums; A Curtis; P A Corris
Journal:  Chest       Date:  2001-09       Impact factor: 9.410

Review 7.  Does the use of extended criteria donors influence early and long-term results of lung transplantation?

Authors:  Marco Schiavon; Pierre-Emmanuel Falcoz; Nicola Santelmo; Gilbert Massard
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-25

8.  Defining an extended criteria donor lung: an empirical approach based on the Eurotransplant experience.

Authors:  Jacqueline M Smits; Wim van der Bij; Dirk Van Raemdonck; Erwin de Vries; Axel Rahmel; Guenther Laufer; Michel De Pauw; Bruno Meiser
Journal:  Transpl Int       Date:  2010-12-13       Impact factor: 3.782

9.  A donor history of smoking affects early but not late outcome in lung transplantation.

Authors:  Takahiro Oto; Anne P Griffiths; Bronwyn Levvey; David V Pilcher; Helen Whitford; Tom C Kotsimbos; Marc Rabinov; Donald S Esmore; Trevor J Williams; Gregory I Snell
Journal:  Transplantation       Date:  2004-08-27       Impact factor: 4.939

10.  Donor smoking history and age in lung transplantation: a revisit.

Authors:  Norihisa Shigemura; Yoshiya Toyoda; Jay K Bhama; Cynthia J Gries; Maria Crespo; Bruce Johnson; Diana Zaldonis; Joseph M Pilewski; Christian A Bermudez
Journal:  Transplantation       Date:  2013-02-15       Impact factor: 4.939

  10 in total
  2 in total

Review 1.  Lung cancer: a rare indication for, but frequent complication after lung transplantation.

Authors:  Dirk Van Raemdonck; Robin Vos; Jonas Yserbyt; Herbert Decaluwe; Paul De Leyn; Geert M Verleden
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

2.  Short- and Long-Term Impact of Smoking Donors in Lung Transplantation: Clinical and Pathological Analysis.

Authors:  Marco Schiavon; Andrea Lloret Madrid; Francesca Lunardi; Eleonora Faccioli; Giulia Lorenzoni; Giovanni Maria Comacchio; Alessandro Rebusso; Andrea Dell'Amore; Marco Mammana; Samuele Nicotra; Fausto Braccioni; Dario Gregori; Emanuele Cozzi; Fiorella Calabrese; Federico Rea
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.